IP Library Granted Patent US 11,318,468
Granted Patent B2
US 11,318,468 · App. 15/547,769 · Granted May 3, 2022

Blister assembly

Inventor: Tom Edwards (Salisbury, GB)
Assignee: Binx Health Limited
B01L3/502738B01L3/502707B01L3/523B01L3/527B32B3/266B32B3/30B32B5/142B32B7/05B32B7/12B32B15/08B32B15/20B32B27/08B32B27/32B32B27/36B65B3/003B65B9/042B65B39/007B65B47/00B65D75/367B01L3/502715B01L2200/0689B01L2200/12B01L2300/044B01L2300/0887B01L2400/0683B32B2255/06B32B2255/10B32B2255/26B32B2307/31B32B2307/50B32B2307/582B32B2307/7246B32B2439/80B65B39/12B65B47/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,318,468
App. No.
15/547,769
Granted
May 3, 2022
Kind
B2
Abstract

A blister assembly comprises at least one collapsible blister adapted, as it is collapsed, to eject a liquid contained therein. The blister assembly comprises a first layer ( 130 ) having at least one blister chamber ( 150 ) and a second layer ( 131 ) sealed to the first layer at least around a periphery of the at least one blister chamber such that a liquid is contained between the first layer and the second layer. The seal between the first and second layers comprises a first planar portion having a first peel strength and a second planar portion having a second peel strength, wherein the first peel strength is greater than the second peel strength, such that when pressure is applied to the blister, the second portion of the seal breaks to release the liquid contained within the chamber into the liquid inlet. The blister assembly further comprises at least one discontinuity ( 142 ) formed in the first and second layers in the region of the first portion of the seal, such that a shear force is required to delaminate the first and second layers in that region.

Claims (22)

1. A blister assembly comprising:

a first layer having at least one blister chamber;

a second layer sealed to the first layer, at least around a periphery of the at least one blister chamber, such that a liquid is contained between the first layer and the second layer, wherein the seal between the first and second layers comprises a first planar portion having a first peel strength and a second planar portion having a second peel strength, and wherein the second peel strength is greater than the first peel strength, such that when pressure is applied to the blister, the first planar portion of the seal breaks to release the liquid contained within the chamber into a liquid inlet; and

at least one discontinuity comprising a pimple formed in the first and second layers in a region of the second planar portion of the seal, the first and second layers remaining sealed to each other throughout the discontinuity such that a shear force is required to delaminate the first and second layers in said region of the second portion of the seal, causing the second peel strength to be greater than the first peel strength.

2. The blister assembly of claim 1 , comprised in a fluidic cartridge for carrying out a diagnostic test on a sample introduced into the cartridge.

3. The blister assembly of claim 1 , wherein the at least one discontinuity has a substantially circular footprint.

4. The blister assembly of claim 1 , wherein the at least one discontinuity protrudes from the blister assembly in the same direction as the collapsible blister.

5. The blister assembly of claim 1 , wherein the blister assembly defines a first plane P, from which the at least one collapsible blister and the at least one discontinuity project, and wherein the profile of the discontinuity comprises first and second side portions and an end portion connecting the first and second side portions.

6. The blister assembly of claim 5 , wherein at least a portion of the first and/or second side portions of the discontinuity is aligned radially to the blister.

7. The blister assembly of claim 5 , wherein a profile of the at least one discontinuity has a height of between 0.1 mm and 1.5 mm.

8. The blister assembly of claim 6 , wherein at least one of the first and second side portions extend at an angle α from a plane perpendicular to the plane P, wherein α is less than 30 degrees.

9. The blister assembly of claim 8 , wherein α is less than 15 degrees.

10. The blister assembly of claim 8 , wherein α is 0 degrees.

11. The blister assembly of claim 1 , wherein the profile of the at least one discontinuity is approximately hemispherical.

12. The blister assembly of claim 1 , wherein a profile of the at least one discontinuity has a width of between approximately 0.5 mm and 3 mm.

13. The blister assembly of claim 1 , comprising a plurality of discontinuities.

14. The blister assembly of claim 13 , wherein the plurality of discontinuities are arranged as a dotted or dashed line around at least a portion of the permanent seal.

15. The blister assembly of claim 1 , comprising two or more collapsible blisters, wherein the at least one discontinuity is formed between the collapsible blisters.

16. The blister assembly of claim 1 , wherein the first layer and the second layer comprise a plastic coated foil.

17. The blister assembly of claim 1 , wherein at least one of the first portion of the seal and the second portion of the seal is formed by heat sealing.

18. The blister assembly of claim 1 , comprising first, second and third collapsible blisters, and the liquid contained in the first, second and third blisters are liquid reagents necessary for conducting a preferred test on a sample contained within a fluidic cartridge.

19. The blister assembly of claim 18 , wherein the reagents are selected from lysis buffer, wash buffer and elution buffer.

Assignments (6)
SECURITY INTEREST Recorded Mar 25, 2025
From: BINX HEALTH LIMITED
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070620/0287 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2025
From: BX HEP AGGREGATOR, LLC,
To: BINX HEALTH LIMITED
Reel/Frame 069925/0466 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT Recorded Oct 3, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: BX HEP AGGREGATOR, LLC
Reel/Frame 069107/0116 →
PATENT SECURITY AGREEMENT Recorded Apr 7, 2021
From: BINX HEALTH LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 055859/0724 →
CHANGE OF NAME Recorded Dec 12, 2019
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 051264/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2017
From: EDWARDS, TOM
To: ATLAS GENETICS LIMITED
Reel/Frame 043359/0149 →
Priority Claims (1)
GB 1501708 · Feb 2, 2015 · national
Continuity (1)
Related Publication 20180015468A1 · Jan 18, 2018